Guidelines outline diagnosis and treatment of GERD in pregnant women :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Experts issue consensus guidelines on GERD management during pregnancy

Gastroesophageal reflux disease in pregnancy Gastroesophageal reflux disease in pregnancy
Gastroesophageal reflux disease in pregnancy Gastroesophageal reflux disease in pregnancy

What's new?

Pregnancy-related GERD is best managed using symptom-based diagnosis, lifestyle modification, and stepwise pharmacological therapy, with alginates/antacids first and H2RAs or PPIs reserved for refractory symptoms.

Gastroesophageal reflux disease (GERD) is highly prevalent during pregnancy, yet its evaluation and treatment have lacked uniform, locally relevant guidance. Clinical practice has often depended on Western recommendations that may not align with Indian dietary patterns, medication access, or real-world diagnostic constraints. To address this unmet need, a national panel of Indian gastroenterologists and gynaecologists has developed India-specific, consensus-based recommendations for the diagnosis and management of GERD in pregnancy.

Using a modified Delphi method, a three-member steering committee of gastroenterologists reviewed the literature and identified 65 relevant studies, which informed nine pilot consensus statements. An expert panel of 15 clinicians (9 gastroenterologists and 6 gynaecologists) from across India was then convened. Evidence summaries were shared 1 month in advance, followed by an in-person consensus meeting to discuss and refine the statements.

The revised statements were circulated electronically for voting using a 5-point Likert scale, with consensus predefined as ≥80% agreement. Results were reviewed by the steering committee and finalised during a virtual meeting, after which the manuscript was drafted and approved.

Key Consensus Statements (100% Agreement)

All final recommendations achieved unanimous (100%) agreement, underscoring strong expert alignment:

  1. High prevalence – Symptoms of gastroesophageal reflux are common during pregnancy.
  2. Quality-of-life impact – GERD symptoms are linked with impaired health-related quality of life in pregnant women.
  3. Symptom-based diagnosis – Diagnosis of GERD during pregnancy must rely primarily on clinical symptoms rather than routine investigations.
  4. Restricted use of endoscopy – Upper gastrointestinal endoscopy should be postponed until the postpartum period, except when alarm features are present.
  5. Lifestyle-first approach – Lifestyle and dietary modifications should be the initial step in management.
  6. Stepwise pharmacotherapy –
  • Alginates or antacids are advocated as the first-line pharmacological treatment when lifestyle measures are insufficient.
  • Histamine-2 receptor antagonists (H2RAs) or proton pump inhibitors (PPIs) are valuable options and may be used if symptoms are not adequately controlled with alginates or antacids alone.

These consensus recommendations yield a clear, pragmatic framework for tackling GERD in pregnancy. By emphasizing symptom-based diagnosis, avoidance of unnecessary endoscopy, lifestyle interventions, and rational, step-up pharmacological therapy, the guidance supports safe, effective, and context-appropriate care for pregnant women with reflux symptoms.

Source:

Journal of Obstetrics and Gynaecology

Article:

Expert consensus for the management of gastroesophageal reflux disease in pregnancy: collaborative insights from experts in India

Authors:

Aniruddha Pratap Singh et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: